Atsena Therapeutics
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
1
Funding Rounds
$150.0m
Money raised
Overview
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Atsena Therapeutics has raised a total of $150m in funding over 1 rounds.
Key Insights:
- Atsena Therapeutics April 2025 Series C Funding Round: $150m
Atsena Therapeutics April 2025 Series C Funding Round
$150m
Industries
Atsena Therapeutics is active in the following industries: